Figure 3From: Stage and tissue-specific prognostic impact of miR-182 in NSCLC Disease-specific survival curves according to tumor cell expression of A) miR-182 in SCC, B) miR-182 in AC, C) miR-182 in LCC, D) miR-182 in stage I patients, E) miR-182 in stage II patients, F) miR-182 in stage III patients. Back to article page